Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies (Details Narrative)

v3.10.0.1
Commitments and Contingencies (Details Narrative)
3 Months Ended 6 Months Ended
Apr. 05, 2018
EUR (€)
Mar. 22, 2018
USD ($)
Jun. 14, 2017
USD ($)
Sep. 14, 2015
USD ($)
Dec. 24, 2013
USD ($)
Jun. 30, 2018
USD ($)
Jun. 30, 2017
USD ($)
Jun. 30, 2018
USD ($)
Jun. 30, 2017
USD ($)
Dec. 31, 2017
USD ($)
Research and development costs           $ 41,106 $ 14,559 $ 66,795 $ 157,803  
Amortizing the retainer payment           2,294   2,294    
Unamortized balance of the retainer payment           16,054   16,054    
Unamortized balance of the retainer payment classified as a current asset           9,174   9,174    
Unamortized balance of the retainer payment classified as a non-current asset           6,880   6,880  
Aggregate principal cash obligation and commitments amount           105,740   105,740    
Principal cash obligations and commitments included in current liabilities           62,440   62,440    
Collaboration Agreement Bio PharmaWorks LLC [Member]                    
Consulting and advisory fees       $ 10,000            
Collaboration agreement value           0 30,000 10,000 30,000  
NDA Consulting Corp [Member]                    
Consulting and advisory fees         $ 4,000 4,000 $ 4,000 8,000 $ 8,000  
NINDS [Member]                    
Accrued expenses           50,000   50,000    
Materials Cooperative Research and Development Agreement [Member]                    
Funds provide for use in acquiring technical, statistical and administrative support for research activities     $ 100,000              
Research and development costs           $ 12,500   25,000    
Materials Cooperative Research and Development Agreement [Member] | First Installment [Member] | July 9, 2017 [Member]                    
Paid two equal installments               50,000    
Materials Cooperative Research and Development Agreement [Member] | Second Installment [Member] | June 14, 2018 [Member]                    
Paid two equal installments               $ 50,000    
Material Transfer Agreement [Member] | Development Milestones [Member] | INSERM [Member] | Maximum [Member]                    
Milestone payments   $ 1,750,000                
Material Transfer Agreement [Member] | Commercial Milestones [Member] | INSERM [Member] | Maximum [Member]                    
Milestone payments   $ 6,500,000                
Consulting Agreement with Liberi Life Consultancy BV [Member]                    
Agreement term 2 years                  
Payments received from sales of products percentage 1834800.00%                  
Net payments of sales of products or licensing activities, percentage 2.50%                  
Consulting Agreement with Liberi Life Consultancy BV [Member] | EURO [Member]                    
One time retainer | € € 15,000